Congressional Hearing on the Pet Medication Industry
January 1, 2016
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing explored regulatory and market dynamics affecting how pet owners access and purchase medications for their animals, which impacts the cost and availability of veterinary care.
Potentially affected actors named in the source documents. Mention is not a position.
Pet owners
The regulatory environment for pet medications directly influences the cost and accessibility of treatments for their animals.
Veterinarians
Veterinarians are involved in the prescribing and dispensing of medications, which is subject to industry regulations and market practices.
Pet medication manufacturers
Manufacturers are subject to federal trade and health regulations discussed during the hearing.
Last recorded activity January 1, 2016.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on April 29, 2016, by the Subcommittee on Commerce, Manufacturing, and Trade.
- The session focused on the 'Pet Medications Industry: Issues and Perspectives'.
- Testimony was provided by representatives from the Federal Trade Commission, True Science, LLC, and the American Veterinary Medical Association.
- The record includes submitted statements from the Animal Health Institute and the Consumers Union.
- The hearing was conducted during the 114th Congress, Second Session.
Frequently Asked Questions
What was the purpose of this hearing?
Who testified at the hearing?
Why It Matters
The hearing explored regulatory and market dynamics affecting how pet owners access and purchase medications for their animals, which impacts the cost and availability of veterinary care.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Historical Regulatory Review
The hearing serves as a snapshot of the 2016 regulatory landscape regarding the intersection of veterinary practice and the retail pet medication market.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools